Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Iron + zinc + folic acid is a combination medication that belongs to the class of drugs called 'hematinic', primarily used to prevent and treat low levels of folic acid, zinc, and iron in blood during certain health conditions such as anemia, pregnancy, poor diet, and surgery recovery. Iron is an essential mineral needed by the body to produce red blood cells and carry oxygen throughout the body. Zinc is required for the immune system to function properly, playing a role in cell growth, division, wound healing, and proper metabolism of iron. Folic acid is a vitamin B that helps the body form healthy cells, especially red blood cells, and is crucial during pregnancy to prevent birth defects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on iron + zinc + folic acid.